Use of antidementia drugs and risk of pneumonia in older persons with Alzheimer’s disease

An investigation of multimorbidity measures as risk factors for pneumonia in elderly frail patients admitted to hospital

(2016) Andrea Ticinesi et al.   European Journal of Internal Medicine

Efficacy of rivastigmine tartrate, transdermal system, in Alzheimer’s disease

(2016) Rachel A. Nieto et al.   EXPERT OPINION ON PHARMACOTHERAPY

From prescription drug purchases to drug use periods – a second generation method (PRE2DUP)

(2015) Antti Tanskanen et al.   BMC Medical Informatics and Decision Making

A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence

(2015) Jacob S. Buckley et al.   DRUGS & AGING

Risk of Pneumonia in New Users of Cholinesterase Inhibitors for Dementia

(2015) Edward Chia-Cheng Lai et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old—Taiwan's PPV vaccination program

(2015) Ying-Huang Tsai et al.   VACCINE

Memantine Monotherapy for Alzheimer’s Disease: A Systematic Review and Meta-Analysis

(2015) Shinji Matsunaga et al.   PLoS One

Risk Factors for Aspiration Pneumonia in Older Adults

(2015) Toshie Manabe et al.   PLoS One

Dementia and Cognitive Impairment

(2014) Julie Hugo et al.   CLINICS IN GERIATRIC MEDICINE

A Systematic Review and Meta-Analysis Examining Pneumonia-Associated Mortality in Dementia

(2014) Norine C. Foley et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

A Benefit–Risk Assessment of the Use of Proton Pump Inhibitors in the Elderly

(2014) Gwen M. C. Masclee et al.   DRUGS & AGING

High prevalence of psychotropic drug use among persons with and without Alzheimer׳s disease in Finnish nationwide cohort

(2014) Heidi Taipale et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Antidementia drug use among community-dwelling individuals with Alzheimer’s disease in Finland

(2014) Heidi Taipale et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Safety of long-term PPI therapy

(2013) Christina Reimer   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Use of existing data sources in clinical epidemiology: Finnish health care registers in Alzheimer’s disease research – the Medication use among persons with Alzheimer’s disease (MEDALZ-2005) study

(2013) Anna-Maija Tolppanen et al.   Clinical Epidemiology

Cholinesterase inhibitors and memantine for symptomatic treatment of dementia

(2012) J. Rodda et al.   BMJ-British Medical Journal

Opioid Drug Abuse and Modulation of Immune Function: Consequences in the Susceptibility to Opportunistic Infections

(2011) Sabita Roy et al.   Journal of Neuroimmune Pharmacology

The clinical (ir)relevance of opioid-induced immune suppression

(2010) Heike L Rittner et al.   Current Opinion in Anesthesiology

Hospitalization in Community-Dwelling Persons with Alzheimer's Disease: Frequency and Causes

(2010) James L. Rudolph et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Memantine Dosing in Patients With Dementia

(2009) Christian Dolder et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

The Clinical Course of Advanced Dementia

(2009) Susan L. Mitchell et al.   NEW ENGLAND JOURNAL OF MEDICINE

Concurrent Use of Anticholinergic Drugs and Cholinesterase Inhibitors

(2008) Kristina Johnell et al.   DRUGS & AGING

Goodness-of-fit diagnostics for the propensity score model when estimating treatment effects using covariate adjustment with the propensity score

(2008) Peter C. Austin   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY